Pomalidomide: An oral administration capsule

Indianpharma30 May, 2022Health

The medicine Pomalidomide was approved by the FDA in 2013 to treat patients with multiple myeloma and has received at least two therapies before, including lenalidomide and bortezomib. Pomalidomide is an analogue of thalidomide, is an immunomodulatory agent with antineoplastic activity. In in vitro cellular assays, Pomalidomide inhibited the proliferation and apoptosis of hematopoietic tumor cells. Pomalidomide capsules come in 1mg, 2 mg and 4 mg to consume orally via the mouth. The active ingredient in the capsule is Pomalidomide with inactive ingredients mannitol, pregelatinized starch, and sodium stearyl fumarate. No specific information is available on the treatment of overdose with Pomalidomide, and it is unknown whether Pomalidomide or its metabolites are dialyzable. If someone takes an overdose, consult the doctor immediately. Pomalidomide cost is inexpensive and easily available from multiple generic medicine suppliers. To know more about Pomalidomide, ring us on 18008891064.